Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

NCT00786474 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00786474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00786474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
Lead sponsor
Duke University
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2009
Completion date
February 28, 2015
Enrollment
1,884 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial thromboembolic events, atrial fibrillation